معرفی
Kendra Shaw is an active medical researcher with significant contributions to understanding post-COVID-19 conditions, particularly focusing on dyspnea, sleep disturbances, and immune responses. With 165 total citations, her work has been prominently featured in high-impact journals including The Lancet series and Immunity and Ageing.
Dr. Shaw's research interests center around the long-term effects of viral infections, particularly SARS-CoV-2, with emphasis on respiratory symptoms, sleep disorders, and immune system changes. Her work spans both acute and chronic phases of illness, from initial hospitalization through long-term recovery. She has made notable contributions to understanding the relationship between sleep quality and respiratory outcomes following COVID-19 infection.
Her four major publications reveal a research trajectory focused on patient-centered outcomes, with particular attention to dyspnea management, pulmonary rehabilitation, and the intersection of sleep medicine with respiratory health. The 2023-2024 publications demonstrate her active involvement in the PHOSP-COVID consortium, contributing to large-scale, multicenter studies that have shaped our understanding of post-acute sequelae of SARS-CoV-2 infection.
Her work has received substantial media attention, with coverage by 73 news outlets, mentions by 100 X users, and appearances on Facebook pages. Additionally, her research has been referenced in policy discussions and has accumulated significant academic readership across platforms like Mendeley.
Dr. Shaw's research contributes to multiple UN Sustainable Development Goals, particularly those related to good health and well-being. Her fingerprint analysis reveals concentrated expertise in dyspnea (100%), COVID-19 (100%), post-COVID-19 conditions (54%), cohort analysis (50%), sleep disorders (50%), and lung function (50%).
